$THC

Tenet Healthcare stock rises 2% on earnings beat and raised guidance

Tenet Healthcare (NYSE:THC) reported Q3 2026 adjusted EPS of $6.64, beating estimates by $1.97. Revenue was $5.63B, up 6.5% YoY. The company raised full-year 2026 adjusted EBITDA guidance to $5.05B-$5.20B and adjusted free cash flow guidance to $2.825B-$3.125B. Shares rose 2.05% in pre-market trading.

Original reporting
Published Oct 29, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The earnings beat and guidance lift are likely to attract buying interest, supporting a near‑term price rally.

02

Market read

Strong earnings and guidance raise make THC a short‑term buying candidate.

03

What to watch

Potential headwinds from regulatory changes or payer mix shifts are not addressed in the release.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Tenet Healthcare (NYSE:THC) posted Q3 2026 results with adjusted EPS $6.64 vs $4.67 consensus and raised FY2026 EBITDA and EPS guidance.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Tenet Healthcare reported Q3 earnings that beat estimates and raised full-year guidance, causing a 2% pre‑market price rise.

Expected impact

likely upward pressure as investors price in the improved outlook

Evidence & confidence

The beat was $1.97 above EPS consensus and guidance was raised by $195 M at the midpoint, a material improvement.

Market effects

Healthcare services sector may see modest upside as Tenet's results set a positive tone.

U.S. hospital and ambulatory‑care stocks could benefit from the guidance lift.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pull‑back.

Key entities

  • Tenet Healthcare Corporation

    U.S. healthcare services provider reporting earnings.

Related articles

$THCMedAI 9/10

Tenet Healthcare Boosts FY26 Earnings Outlook - Update

Tenet Healthcare (THC) raised its FY26 earnings and adjusted earnings guidance, while narrowing its revenue outlook. The company now expects earnings of $35.82-$37.08 per share, adjusted earnings of $22.05-$23.01 per share, and revenue of $22.05-$22.45 billion. Shares were unchanged at $268.50 in pre-market trading.

$THCHighAI 9/10

Tenet Healthcare (NYSE:THC) exceeds Q3 2026 expectations

Tenet Healthcare (THC) reported Q3 2026 revenue of $5.63B, beating estimates by 2.1% and growing 6.5% YoY. Adjusted EPS of $6.64 surpassed expectations by 42%. The company raised full-year revenue guidance to $22.25B and adjusted EPS guidance to $22.53. Operating and free cash flow margins improved significantly.

$THCMedAI 8/10

Tenet: Q3 Earnings Snapshot

Tenet Healthcare Corp. (THC) reported Q3 earnings of $1B, or $12.41 per share, beating expectations. Revenue was $5.63B, also exceeding forecasts. The company raised its full-year guidance to $22.05-$23.01 per share in earnings and $22.05B-$22.45B in revenue.

$THCHighAI 9/10

Tenet Reports Strong Third Quarter 2026 Results

TENET HEALTHCARE CORP (THC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook • Net income available to common shareholders in third quarter 2026 was $1.000 billion, or $12.41 per diluted share compared to $342 million, or $3.86 in third quarter 2025 • Adjusted dilu